Detailed answers about GLOBAL INST. FOR NOVEL NICOTINE (GINN) LTD, including incorporation, status, business activity, and accounts information.
When was GLOBAL INST. FOR NOVEL NICOTINE (GINN) LTD founded?
GLOBAL INST. FOR NOVEL NICOTINE (GINN) LTD was officially incorporated on 27 December 2024 and is registered under company number 16153379. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is GLOBAL INST. FOR NOVEL NICOTINE (GINN) LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of GLOBAL INST. FOR NOVEL NICOTINE (GINN) LTD?
GLOBAL INST. FOR NOVEL NICOTINE (GINN) LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does GLOBAL INST. FOR NOVEL NICOTINE (GINN) LTD do?
GLOBAL INST. FOR NOVEL NICOTINE (GINN) LTD operates in the following sector: 94110 - Activities of business and employers membership organizations. This provides insight into the company's primary business activity and industry focus.
What is GLOBAL INST. FOR NOVEL NICOTINE (GINN) LTD's registered address?
The registered office address of GLOBAL INST. FOR NOVEL NICOTINE (GINN) LTD is OFFICE 316 IMPERIAL CHAMBERS 10-17 SEVEN WAYS PARADE, WOODFORD AVENUE, LONDON, ENGLAND, IG2 6JX. This is the official address filed with Companies House for legal and statutory correspondence.
Is GLOBAL INST. FOR NOVEL NICOTINE (GINN) LTD financially stable?
Financial accounts for GLOBAL INST. FOR NOVEL NICOTINE (GINN) LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.